PATENT CLAIM ANALYSIS

Application Number: 15908659
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["424", "178100"]

Abstract:
Compositions including an antibody single-chain variable fragment (scFv) conjugate that specifically binds to ROR1 tumor-associated antigen are provided. The anti-ROR1 scFv antibody and conjugates may include a biologically-active molecule. Such conjugates may comprise a chimeric receptor to direct T cells to respond to ROR1 cancer cells, Methods to use the scFV conjugates to target cells expressing ROR1 for therapeutic and diagnostic purposes are also provided.

Claim (Index 43):
The method of  claim 38 , wherein said cancer comprises a lymphoma or leukemia.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.39216
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14973486', '13703864', '15619119', '12545731', '14422519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7856649222743033
- 35 USC 102 Novelty (BERT): 0.5794326090568234
- Combined Prediction Score: 0.7650416909525554
- Mean Citation Score: 450.89352
- Max Citation Score: 613.11084
- Similarity Product: 345.29156162637946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test